Nanexa and Moderna partner on ALD-based PharmaShell drug delivery platform in licensing deal with USD 3 million upfront payment

Nanexa and Moderna have entered into a license and option agreement covering the development of up to five undisclosed drug compounds using Nanexa’s PharmaShell® drug delivery platform. The agreement includes an upfront payment of USD 3 million to Nanexa, with the potential for up to USD 500 million in development and commercial milestone payments, as well as tiered single-digit royalties on…